CRESEMBA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Isavuconazonium Sulfate.
| Product ID | 0469-0520_034e698e-c634-4372-9a9a-89ca83dc0a80 |
| NDC | 0469-0520 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CRESEMBA |
| Generic Name | Isavuconazonium Sulfate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-11-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207500 |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | ISAVUCONAZONIUM SULFATE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2015-11-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA207500 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-11-04 |
| Ingredient | Strength |
|---|---|
| ISAVUCONAZONIUM SULFATE | 186 mg/1 |
| SPL SET ID: | 8f7f73b8-586a-4df0-935f-fecd4696c16c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0469-0420 | CRESEMBA | isavuconazonium sulfate |
| 0469-0520 | CRESEMBA | isavuconazonium sulfate |
| 0469-2860 | CRESEMBA | isavuconazonium sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CRESEMBA 87380656 5363262 Live/Registered |
Astellas US LLC 2017-03-22 |
![]() CRESEMBA 85967909 4532336 Live/Registered |
Astellas Pharma Inc. 2013-06-24 |